Last reviewed · How we verify
Anemia of prematurity — Treatment Landscape & Competitive Intelligence
4 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Glucoferron | FERROUS GLUCONATE | Sanofi | Vitamin C [EPC] | 1999-01-01 | ||
| Iron Fumarate | FERROUS FUMARATE | Pfizer | Vitamin C [EPC] | 1986-01-01 | ||
| FERROUS SULFATE | FERROUS SULFATE | Pfizer | ferrous sulfate | 1946-01-01 | ||
| Elemental Iron (As Carbonyl Iron) | Iron | Hippocration General Hospital | Vitamin C [EPC] |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 2 drugs in Anemia of prematurity
- · 1 drug in Anemia of prematurity
- Hippocration General Hospital · 1 drug in Anemia of prematurity
- Sanofi · 1 drug in Anemia of prematurity
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Anemia of prematurity:
- Anemia of prematurity treatment updates — RSS
- Anemia of prematurity treatment updates — Atom
- Anemia of prematurity treatment updates — JSON
Cite this brief
Drug Landscape (2026). Anemia of prematurity — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/anemia-of-prematurity. Accessed 2026-06-10.
Related
- Anemia of prematurity full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing